Home » Topics » BioWorld Science

BioWorld Science
RSS

BE-43767A: Banyu's most active novel antibacterial from new series

July 19, 1996

Antibacterial cephalosporins described by Lilly

July 19, 1996

Antibacterial naphthyridines in Cheil Foods & Chemicals' pipeline

July 19, 1996

FDA approval granted for Candela's ALEXlazr

July 19, 1996

Vanguard Medica exercises worldwide rights to VML-262

July 19, 1996

Penederm files FDA amendment regarding Avita

July 19, 1996

Taro's clobetasol propionate approved by FDA

July 19, 1996

Stiefel to develop and market CytoMed's CMI-392

July 19, 1996

5-HT1-like receptor agonists as migraine treatment from Merck & Co.

July 19, 1996

BTG-2403: representative opioid analgesic

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...